Archive: 06/06/2013

Added benefit of dapagliflozin is not proven

Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal ...

Being well received in care speeds up healing process

A placebo can activate a number of biological mechanisms in the same way that medicine can, which is why we are now beginning to understand why a placebo can heal and alleviate symptoms. Psychosocial factors, such as words ...

Added benefit of ingenol mebutate is not proven

The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act ...

page 5 from 8